scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1001180857 |
P356 | DOI | 10.1046/J.1523-1747.1999.00491.X |
P698 | PubMed publication ID | 9989793 |
P5875 | ResearchGate publication ID | 13299258 |
P2093 | author name string | M Chen | |
J C Jones | |||
E A O'Toole | |||
D T Woodley | |||
M P Marinkovich | |||
Y Y Li | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 177-83 | |
P577 | publication date | 1999-02-01 | |
P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
P1476 | title | NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats | |
P478 | volume | 112 |
Q37526593 | A combinatorial cell-laden gel microarray for inducing osteogenic differentiation of human mesenchymal stem cells |
Q35891192 | A novel laminin β gene BmLanB1-w regulates wing-specific cell adhesion in silkworm, Bombyx mori |
Q45956637 | Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa. |
Q38772377 | Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy |
Q34015563 | Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays |
Q52542277 | Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype. |
Q34582955 | Bridging structure with function: structural, regulatory, and developmental role of laminins |
Q38942490 | Clinical features and diagnosis of epidermolysis bullosa acquisita |
Q22252408 | Cutaneous manifestations of gastrointestinal disease |
Q33875126 | Defining the role of laminin-332 in carcinoma |
Q35119599 | Epidermal basement membrane zone components: ultrastructural distribution and molecular interactions |
Q38078021 | Epidermolysis bullosa acquisita |
Q34436682 | Epidermolysis bullosa acquisita: update and review |
Q33699348 | Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer |
Q37484666 | Fluorescent protein markers to tag collagenous proteins: the paradigm of procollagen VII. |
Q55428949 | Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction. |
Q55262188 | Humoral Epitope Spreading in Autoimmune Bullous Diseases. |
Q28508123 | Insight into interactions of the von-Willebrand-factor-A-like domain 2 with the FNIII-like domain 9 of collagen VII by NMR and SPR |
Q45877035 | Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo |
Q40704596 | Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice. |
Q46415616 | Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing |
Q34569918 | Lack of nidogen-1 and -2 prevents basement membrane assembly in skin-organotypic coculture |
Q35582639 | Laminin 332 deposition is diminished in irradiated skin in an animal model of combined radiation and wound skin injury |
Q42693930 | Laminin deposition in the extracellular matrix: a complex picture emerges |
Q37161422 | Laminin-332 and -511 in skin. |
Q39941224 | Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression |
Q37239714 | Laminin-332-integrin interaction: a target for cancer therapy? |
Q34403741 | Molecular organization of the cutaneous basement membrane zone |
Q46609756 | Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. |
Q28084472 | Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies |
Q40661757 | Regulation of interleukin-1alpha expression by integrins and epidermal growth factor receptor in keratinocytes from a mouse model of inflammatory skin disease |
Q89592023 | Structural and biophysical characterization of the type VII collagen vWFA2 subdomain leads to identification of two binding sites |
Q42514770 | Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases. |
Q36161429 | The alpha-3 polypeptide chain of laminin 5: insight into wound healing responses from the study of genodermatoses |
Q40817995 | The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies |
Q35855573 | The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. |
Q28658779 | The cysteine-rich region of type VII collagen is a cystine knot with a new topology |
Q34646757 | The laminin family |
Q30829032 | The lupus band: do the autoantibodies target collagen VII? |
Q24678464 | The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion |
Q37583348 | Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes. |
Q42450363 | Ultrastructural Orientation of Laminin 5 in the Epidermal Basement Membrane: an Updated Model for Basement Membrane Organization |
Q42504595 | Unique mouse monoclonal antibodies reactive with maturation-related epitopes on type VII collagen. |
Q35736256 | Upregulation of gamma-2 laminin-332 in the mouse ear vesicant wound model. |
Q74256789 | [Bullous autoimmune dermatoses. 2: Pathogenesis] |
Search more.